Close Menu

Delaware Biotechnology Institute

Little State, Big Dreams

Premium

The Delaware Biotechnology Institute was started with economic development in mind, but the scientists who call it home say it's been a significant boon to their own research.

William Moffitt signed a three-year contract to remain president and CEO of Nanosphere, while BioTrove's Al Luderer joined Agendia's supervisory board, and more.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.